Nov 2026· International Journal of Molecular Sciences· Vol 27, pp. 10018· 0 citations· 40 references
Medicine
TL;DR
Luteolin and naringenin are potential active constituents of GLTL that suppress proliferation and promote apoptosis in PDGF-BB-stimulated pulmonary arterial smooth muscle cells in vitro, an effect associated with suppression of IGF1R/PI3K/AKT signaling.
Abstract
Pulmonary arterial hypertension (PAH) remains a progressive disease with limited therapies. As part of our continuing study to identify effective agents for PAH from natural herbal medicines, we analyzed the chemical constituents of an empirically validated herbal formula named Guilou Tongluo formula (GLTL) by UHPLC-Q-Exactive MS, retrieved its putative blood-absorbed constituents from databases, and integrated them with lung RNA-sequencing data to discover potential active constituents against PAH. A compound–disease network was constructed; drug–disease intersection genes underwent functional enrichment analysis, whereas hub targets were prioritized by protein–protein interaction analysis. Immune infiltration and single-cell RNA sequencing were used to analyze the vascular microenvironment, while nomogram and decision curve analyses exploratorily assessed the association of candidate targets with disease status at the tissue level. Target engagement was predicted by molecular docking and molecular dynamics simulation and supported by cellular thermal shift and drug affinity target stability assays; the mechanism of the constituents was then examined. The results showed that GLTL attenuated proliferation and promoted apoptosis in PDGF-BB-stimulated pulmonary arterial smooth muscle cells (PASMCs), an effect associated with IGF1R/PI3K/AKT signaling in smooth muscle cells, with IGF1R identified as a key candidate target. Molecular docking and dynamics simulation predicted that naringenin and luteolin could bind IGF1R, and CETSA and DARTS provided experimental support for IGF1R engagement. Both compounds engaged IGF1R and suppressed IGF-1/IGF1R signaling, thereby reducing PI3K/AKT phosphorylation and the expression of Cyclin D1, BCL2, PCNA, and Ki67. In summary, luteolin and naringenin are potential active constituents of GLTL that suppress proliferation and promote apoptosis in PDGF-BB-stimulated PASMCs in vitro, an effect associated with suppression of IGF1R/PI3K/AKT signaling.
INTRODUCTION
Pulmonary Arterial Hypertension (PAH) is a progressive and lifethreatening cardiopulmonary disorder, primarily characterized by sustained elevation of pulmonary vascular resistance and structural remodeling of pulmonary vessels, which eventually leads to right ventricular failure and death. Cuscuta chinens...
Li-Wei Wang, Rui Wang, Jie Wang et al.· Combinatorial chemistry & hi...· 0 citations
Carotid artery atherosclerosis (CAS) is a chronic inflammatory vascular disease in which ferroptosis—an iron-dependent, oxidative form of regulated cell death—has been implicated in endothelial injury and vascular inflammatory responses. Despite growing evidence for the therapeutic potential of Huaban Tongmai decoc...
Jia-Xi Zou, Xiu-Juan Zhou, Ni Jin et al.· Frontiers in Cell and Develo...· 0 citations
Vascular aging is an important pathological basis of hypertension and hypertension-associated target-organ injury. Ginseng-Sanqi-Chuanxiong (GSC) extract has been shown to have protective effects against vascular dysfunction; however, its mechanisms in hypertensive vascular aging remain unclear.
In this stud...
Mei-Yu Cui, Xiao-Hui Yuan, Ying-Kun Fu et al.· Frontiers in Pharmacology· 0 citations
Background: Pulmonary arterial hypertension (PAH) is a progressive fatal cardiovascular disorder characterized by pulmonary vascular remodeling, elevated pulmonary vascular resistance and right heart failure, mainly driven by chronic inflammation and aberrant cell death. Scutellarin (SCU), a natural flavonoid with anti...
BACKGROUND
Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR), ultimately culminating in right ventricular failure and death. Although previous studies have demonstrated that stigmasterol (STG) reduces cholesterol levels and prevents cardiovascular dis...
Yuan Tang, Yan-Ping Shi, Meng-Ting Wang et al.· European Journal of Pharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.